Skip to main navigation Skip to search Skip to main content

A phase 1b multicenter open label dose escalation study to evaluate the safety tolerability pharmacokinetics and pharmacodynamics of subcutaneously administered mosunetuzumab to participants with systemic lupus erythematosus

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date01/6/22 → 01/5/26

Funding

  • Genentech Incorporated: $40,771.80